Navigation Links
Clinical Site Services Is Bringing 3x More Patient Enrollment to the 48th Annual DIA Meeting
Date:6/21/2012

GLEN BURNIE, Md., June 21, 2012 /PRNewswire/ -- Clinical Site Services (CSS), a Maryland company focused on managing the trial enrollment process for sponsor companies, CROs and investigative sites, is pleased to announce that they will be exhibiting at the 48th annual meeting of the Drug Information Association (DIA). The conference will be held on June 24th - June 28th, 2012 at the Philadelphia Convention Center in Philadelphia, PA.

The DIA 2012 48th Annual Meeting is the premier event for professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related products.

Chris Trizna, President, and Charlie Speno, VP/Business Development, will be on hand to demonstrate their global patient enrollment and retention solutions and discuss how the CSS team provides "three times more" for its clients.

"CSS is a unique provider in the patient recruitment category," explained Trizna. "We want sponsor companies and CROs to understand how our proprietary solutions can provide enrollment results which are three times greater than those executed on their own. In many programs, we're able to see three times more sites performing when we are brought on board. Other times, our campaigns are three times more efficient in start-up and launch."

"Who couldn't use three times more of a good thing?" added Mr. Trizna.

Stop by Booth #1829 to find out how CSS helps its clients increase site performance, increase patient enrollment and increase retention. CSS will also feature three times the number of giveaways -- one each day -- by raffling off the new iPad and men's and women's Coach travel bags. CSS will also feature three times more power, with cell phone charging stations available for use at no charge.

Clinical Site Services (CSS) is a site performance company that provides solutions to increase the enrollment potential for investigative sites. Through a proprietary, integrated process, CSS strives to reduce the costs and timelines associated with recruitment of subjects for clinical studies.

Contact:

Jennifer Whitlock
Clinical Site Services
P: 443-308-5803
F: 410-553-0087
jwhitlock@clinicalsiteservices.com 
www.clinicalsiteservices.com

Contacts on site:

Chris Trizna
P: 410-991-4632
ctrizna@clinicalsiteservices.com    

Charlie Speno
P: 443-895-0283
cspeno@clinicalsiteservices.com

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Clinical Site Services
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
2. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
3. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
4. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
5. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk Assessment of Coronary Artery Disease
8. First Patient Treated in U.S. Clinical Study of Cohera Medicals TissuGlu® Surgical Adhesive
9. Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
10. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
11. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
Breaking Medicine Technology:
(Date:4/24/2017)... Chicago, Illinois (PRWEB) , ... April 24, 2017 , ... ... home. What happened next changed her life forever. , In “Healing Tears,” James depicts ... “At the advice of my attorney, I began journaling conversations and situations throughout my ...
(Date:4/24/2017)... ... April 24, 2017 , ... ALP Nutrition®, ... supplements, announced its popular products are now available for purchase on StackedNutrition.com, a ... the use of premium natural ingredients in making all of its products. These ...
(Date:4/24/2017)... ... April 24, 2017 , ... My T Chai, a South ... are now available for purchase on RevNutrition.com, a popular website specializing in sales of ... and popularized in ancient India and Siam. It spread across Asia and Africa quickly, ...
(Date:4/24/2017)... HOUSTON, TEXAS (PRWEB) , ... April 24, 2017 ... ... service (SaaS) based healthcare compliance and credentialing solutions, today announced that Kyle Allain ... Allain leads symplr’s Cactus Provider Management sales and operations, including provider, payor and ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... tumors are expected to be diagnosed globally; approximately 25,000 of them will be ... anticipating greater use of this type of healthcare model in the diagnosis and ...
Breaking Medicine News(10 mins):